Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

Nexium image

Teva’s Nexium copycat approved in US

January 27, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, Teva, esomeprazole, gerd, heart, nsaids

Teva has won approval for its copycat form of AstraZeneca’s big-selling heatburn drug Nexium, making it the first generic version …

News
Bennet Building bioscience laboratory image

Bioscience lab opens up in Cambridge

January 20, 2015
Research and Development AstraZeneca, BIA, Babraham Research Campus, Cambridge, Menelas Pangalos

The UK Bennet Building bioscience laboratory doors have been opened during a ceremony at the Babraham Research Campus in Cambridge …

News
eric_terhaerdt_astellas

Astellas takes senior head from AstraZeneca

January 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, AstraZeneca, eric Terhaerdt

Eric Terhaerdt has been named as the senior vice president of global development operations at Astellas Pharma. Terhaerdt, who joins the …

Appointment
Brilinta image

AstraZeneca’s troubled Brilinta gets welcome lift

January 14, 2015
Sales and Marketing AstraZeneca, Brilinta, FDA, US Department of Justice, acute coronary syndrome, ticagrelor

AstraZeneca has reported positive primary endpoint results for its anti-clogging drug Brilinta to treat patients who have had a heart …

News
AZ image

AstraZeneca drops CDF application

January 12, 2015
Sales and Marketing AstraZeneca, CDF, Cancer, NHS, NICE, lynparza, olaparib

AstraZeneca has withdrawn its application for its drug Lynparza to be on the Cancer Drugs Fund (CDF), citing concerns with …

News
Astrazeneca image

AstraZeneca ovarian cancer drug approved in Europe

December 18, 2014
Sales and Marketing AstraZeneca, BRCA, Cambridge, Cancer, FDA, lynparza, olaparib, ovarian

The European Commission has approved AstraZeneca’s Lynparza for the treatment of advanced BRCA-mutated ovarian cancer. Lynparza (olaparib) has been approved …

News
AZ image

AstraZeneca closing US manufacturing unit

December 16, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, Pulmicort, malloy, short haircuts, westboro

AstraZeneca is closing its Otis Street manufacturing plant next year that has been in operation for 33 years, and the …

News
AZ image

Pharma to lose $69 billion in five years as patents expire

December 12, 2014
Sales and Marketing AstraZeneca, GlobalData, Japanese firm Otsuka, Otsuka, lilly, pharma

Pharma companies are set to lose around $65 billion by 2019 due to drug patent expiries according to research firm …

News
AZ image

AstraZeneca constipation drug gets EU nod

December 9, 2014
Sales and Marketing AstraZeneca, KODIAC, NKTR-118, PAMORA, moventig, naloxegol

AstraZeneca’s opioid-induced constipation drug Moventig has been approved by the European Commission. The first once-daily PAMORA tablet to be given …

News
Novartis image

AZ triumphs in Nexium pay-for-delay trial

December 8, 2014
Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole

AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …

News
Lilly image

AZ and Lilly Alzheimer’s drug enters trials

December 1, 2014
Research and Development, Sales and Marketing AZD3293, Alzheimer's, AstraZeneca, LY3314814, lilly

AstraZeneca and Eli Lilly have begun a Phase II/II trial for their Alzheimer’s treatment AZD3293 as the companies hope to …

News
AZ campus image

CRUK and AZ collaborate on cancer screening

November 28, 2014
Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, Cancer, Cancer Research UK, MRC

Cancer Research UK (CRUK) scientists are to be given access to drug discovery facilities at AstraZeneca’s Cambridge site as part …

News
AZ image

AZ predicts strong growth ahead of Pfizer deadline

November 19, 2014
Sales and Marketing AZD9291, AstraZeneca, Pfizer, Soriot, definiens

AstraZeneca has announced that it expects to deliver revenues of over $45 billion by 2023 as it makes its final …

News
Digital health image

Numerous prospects in health technology say analysts

November 12, 2014
Medical Communications, Sales and Marketing 3D, AstraZeneca, F&S, app, digital, frost and sullivan, fs, wearables

Medical devices and imaging technology have been included in a recent analysis of the top 50 most innovative technologies. Frost …

News
AZ image

AstraZeneca diabetes drug approved for use in Scotland

November 11, 2014
Sales and Marketing Afinitor, AstraZeneca, Eylea, Onglyza, Perjeta, SMC, diabetes, type 2

The Scottish Medicines Consortium (SMC) has shown AstraZeneca’s Onglyza (saxagliptin) the green light to be used with insulin in patients …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026